Norges Bank Sera Prognostics, Inc. Transaction History

Norges Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2023	BUY	$2.96 - $8.8 $109,810 - $326,462	37,098 New	37,098 $140,000
Q1 2022 May 09, 2022	SELL	$2.96 - $8.8 $109,810 - $326,462	-37,098 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$6.87 - $11.41 $254,863 - $423,288	37,098 New	37,098 $255,000
Q3 2021 Nov 14, 2022	BUY	$7.9 - $13.04 $293,074 - $483,757	37,098 New	37,098 $412,000

19M

35.4K

Ticker SERA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 29,596,900
Market Cap $229M
Description
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.